|
| ||||||||||||||
BIOLASE Conference Call: 2008 Third Quarter and Nine-Month Results IRVINE, Calif., Oct. 30, 2008 (GLOBE NEWSWIRE) -- BIOLASE
Technology, Inc. (NasdaqGM:BLTI - News), the world's leading dental
laser company, announced today that the Company will host
a conference call on Wednesday, November 5 at 4:30 p.m.
Eastern Time to discuss its operating results for the third
quarter and nine months ended September 30, 2008 and to
answer questions. The Company's results release will be
distributed at approximately 4:05 p.m. Eastern Time that
same day. Slides will be used during this call. Directions for accessing the slides, can be found below. Phone Participation To listen to the conference call live via telephone, please dial 1-800-762-8908 from the U.S. or, for international callers, please dial +1-480-629-9041, approximately 10 minutes before the start time. In order to access the slides that will be used on the call, click on the link provided on the Investors section of the BIOLASE website at http://www.biolase.com to listen to the event, register and select the ``No Audio, Slides Only'' option. Webcast Participation To listen to the conference call live via the Internet, visit the Investors section of the BIOLASE website at http://www.biolase.com. Please go to the website 15 minutes prior to the call to register, download and install the necessary audio software. Replay An audio archive of the webcast will be available for one year on the Investors section of the BIOLASE website. About BIOLASE Technology, Inc. BIOLASE Technology, Inc. (http://www.biolase.com), the world's leading dental laser company, develops, manufactures and markets lasers and related products that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets. For further information, please contact: Jill Bertotti, of Allen & Caron, +1-949- 474-4300. Contact: Allen & Caron
Jill Bertotti
+1-949- 474-4300
Source: BIOLASE Technology, Inc.
| ||||||||||||||